About Pierre Fabre Laboratories

Pierre Fabre Laboratories is the world’s second-largest dermo-cosmetics company and one of Europe’s leading pharmaceutical laboratories. Its Dermo-cosmetics & Personal Care portfolio brings together major international brands such Eau Thermale Avène, Ducray, Dexeryl, Klorane, A-Derma, René Furterer, Même Cosmetics et Elgydium. The Pharma activity covers 5 main therapeutic fields: oncology, dermatology, rare diseases, primary care and family health care.  

In 2025, Pierre Fabre Laboratories generated €3.2 billion euros in revenue, 71% of which came from international sales across 130 territories. Based in southwest France since its creation and manufacturing nearly 90% of its products in France, Pierre Fabre Laboratories employs 10,000 people worldwide. R&D investments increased by 14% compared with the previous year, reaching €250 million, 67% of which is dedicated to targeted therapies in oncology.

The majority shareholder of Pierre Fabre Laboratories is the Pierre Fabre Foundation (holding 86.3% of the capital), a humanitarian foundation recognized as being of public utility. The company’s employees are its second-largest shareholder (nearly 10%). This shareholding structure guarantees the company’s independence, its long-term vision and its sustainable contribution to the common good. Dividends paid to the Pierre Fabre Foundation contribute to 35 healthcare-access programs deployed in 22 of the least developed countries in the world.

Since 2023, Pierre Fabre Laboratories’ CSR policy has been assessed by AFNOR Certification and has been awarded the “Exemplary” level of its CSR label (ISO 26 000 standard for sustainable development). 

More information on  www.pierre-fabre.com LinkedIn  –  Facebook  –  Instagram

Updated April 2026